1. Home
  2. CHMI vs RVPH Comparison

CHMI vs RVPH Comparison

Compare CHMI & RVPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Cherry Hill Mortgage Investment Corporation

CHMI

Cherry Hill Mortgage Investment Corporation

HOLD

Current Price

$2.50

Market Cap

93.0M

Sector

Real Estate

ML Signal

HOLD

Logo Reviva Pharmaceuticals Holdings Inc.

RVPH

Reviva Pharmaceuticals Holdings Inc.

HOLD

Current Price

$0.79

Market Cap

10.0M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CHMI
RVPH
Founded
2012
2006
Country
United States
United States
Employees
14
14
Industry
Real Estate Investment Trusts
Biotechnology: Pharmaceutical Preparations
Sector
Real Estate
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
93.0M
10.0M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
CHMI
RVPH
Price
$2.50
$0.79
Analyst Decision
Buy
Strong Buy
Analyst Count
2
7
Target Price
$3.00
$66.67
AVG Volume (30 Days)
234.8K
1.5M
Earning Date
05-05-2026
05-14-2026
Dividend Yield
15.81%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$59.20
N/A
P/E Ratio
$139.30
N/A
Revenue Growth
N/A
N/A
52 Week Low
$2.17
$0.17
52 Week High
$3.14
$3.11

Technical Indicators

Market Signals
Indicator
CHMI
RVPH
Relative Strength Index (RSI) 42.14 43.85
Support Level $2.52 $0.32
Resistance Level $2.74 $0.86
Average True Range (ATR) 0.10 0.19
MACD -0.03 -0.12
Stochastic Oscillator 32.50 6.12

Price Performance

Historical Comparison
CHMI
RVPH

About CHMI Cherry Hill Mortgage Investment Corporation

Cherry Hill Mortgage Investment Corp is a fully integrated, internally managed residential real estate finance company focused on acquiring, investing in and managing residential mortgage assets in the United States. It invests in residential mortgage assets to generate current yields and risk-adjusted total returns for its stockholders over the long term, through dividend distributions and secondarily through capital appreciation. The company's reportable segments include investments in Residential mortgage-backed securities (RMBS), Investments in Servicing Related Assets, and All Others. It generates maximum revenue from the RMBS segment in the form of Interest income earned for servicing mortgage loans.

About RVPH Reviva Pharmaceuticals Holdings Inc.

Reviva Pharmaceuticals Holdings Inc is a late-stage pharmaceutical company that discovers, develops, and seeks to commercialize therapeutics for diseases. The current pipeline of the company focuses on the central nervous system, inflammatory, and cardiometabolic diseases. The company uses a chemical genomics-driven technology platform and proprietary chemistry to develop new medicines. The company's pipeline currently has two drug candidates, Brilaroxazine (RP5063) which is intended to treat multiple neuropsychiatric indications, including schizophrenia, bipolar disorder, depressive disorder, attention-deficit/hyperactivity disorder, behavioral and psychotic symptoms of dementia or Alzheimer's disease and Parkinson's disease psychosis and its other drug candidate is RP1208.

Share on Social Networks: